Key Insights

Highlights

Treatment Research

2 treatments under study, led by Vega Uva Illumination System

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01398852Phase 3TerminatedPrimary

Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia

Showing all 1 trials

Research Network

Common Treatments

  • Vega Uva Illumination System1
  • Riboflavin1

Active Sponsors

  • Topcon Medical Systems, Inc.1

Activity Timeline